Business Segments Morepen Laboratories Limited NSE India S.E.
Stocks
MOREPENLAB
INE083A01026
Pharmaceuticals
|
Market Closed -
NSE India S.E.
07:05:08 2026-08-28 EDT
|
5-day change | 1st Jan Change | ||
| 106.19 INR | +9.81% |
|
+10.60% | +158.56% |
| 08-05 | Morepen Laboratories Limited announces Annual dividend, payable on October 26, 2026 | CI |
| 08-04 | Morepen Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
Geographical Revenue Distribution History
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Medicinal Chemicals and Botanical Products | ||||||||||
Pharmaceutical Business | 11.98B | 15.56B | 14.22B | 17.02B | 18.12B | |||||
Total Assets | 8.58B | 10.7B | 11.1B | 12.93B | 17.78B | |||||
Interest Expense | -17.88M | -24.26M | -19.81M | -37.1M | -77.85M | |||||
Income Tax Expense | 14.22M | 250M | 171M | 388M | 371M | |||||
CAPEX | -404M | -674M | -356M | -714M | -1.24B | |||||
EBT | 985M | 1.27B | 558M | 1.35B | 1.55B | |||||
D&A | 248M | 158M | 126M | 179M | 287M | |||||
Net Income | 971M | 1.02B | 387M | 962M | 1.18B |
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
India | 6.99B | 9.83B | 8.5B | 10.43B | 10.93B | |||||
Rest of World | 4.09B | 4.58B | 4.76B | 4.82B | 5.9B | |||||
United States of America | 680M | 1.01B | 879M | 1.57B | 1.21B |
Select your edition
All financial news and data tailored to specific country editions
